Article

Marijuana Hazard: Stress Cardiomyopathy

Author(s):

Using marijuana may double the risk of stress cardiomyopathy, researchers found.

Even as states move to legalize the use of cannabis, researchers are just beginning to track its physiological impact on users.

In a study presented today at the American Heart Association's Scientific Sessions in New Orleans, LA, Amitoj Singh, MD, and colleagues at St. Luke's University Health Network in Bethlehem, PA, found it can have a harmful effect on the heart.

In a retrospective study, the authors found younger marijuana users were twice as likely as non-users to experience stress cardiomyopathy, a sudden weakening of the heart muscle. The condition is usually temporary, but can result in cardiac arrest and to require an implanted defibrillator.

Compared with non-users, researchers found that marijuana users were more likely to be younger, male, and have few cardiovascular risk factors such as high blood pressure, diabetes and high cholesterol. That meant they were unlikely to develop stress cardiomyopathy, but some of those who used marijuana did.

The researchers found that 2.4% of the marijuana users were likely to go into cardiac arrest after a bout of cardiomyopathy than controls (2.4% vs. 0.8%).

Marijuana users were also far more likely than non-users to have a history of depression (32.9% vs. 14.5%) to smoke tobacco (73.3% vs. 28.6%) and to use multiple substances (11.4%. vs. 0.3%).

Those habits add to the likelihood of developing stress cardiomyopathy so the researchers adjusted for known risk factors to isolation the association between marijuana use and the heart condition.

Among the study limits are the facts that the researchers could not determine how much marijuana the subjects were using or the time between its use and the incidents of cardiomyopathy.

Related Videos
Jörn Schattenberg, MD | Credit: Novo Nordisk
Jörn Schattenberg, MD | Credit: Novo Nordisk
The APAC Recap: Cardiomyopathy at CAPP Live 2024 with Greg Duck, PA-C | Image Credit: APAC
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
The APAC Recap: Peripheral Artery Disease at CAPP Live 2024 with Bob Ross, PA-C | Image Credit: APAC
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Malin Fromme, MD | Credit: RWTH Aachen
Pavel Strnad, MD | Credit: AASLD
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
© 2024 MJH Life Sciences

All rights reserved.